What is the difference between digital PCR and real-time PCR (qPCR)?
qPCR PCR watches fluorescence build up across cycles and compares a threshold (Cq) to a standard curve — so its answer is relative and depends on amplification efficiency. Digital PCR (dPCR) splits the sample into thousands of tiny partitions, runs them to endpoint, and counts positives by Poisson statistics — so its answer is absolute (copies/µL) with no standard curve, and it is far more precise at very low copy numbers. The trade-off: dPCR costs several times more per reaction, has lower throughput, and needs a dedicated instrument.
The Real Question Is Precision vs Practicality
Nearly everyone who searches “dPCR vs qPCR” is really asking: do I actually need the extra precision and cost? The honest answer is that qPCR is what 95% of labs need for routine work, and dPCR is worth its cost only for the specific jobs qPCR is genuinely bad at. This guide is that cost–benefit analysis. Read the exact numbers, then the scenario section, and you’ll know which side you’re on.
How Each Technology Works
qPCR reads fluorescence every cycle. The more starting template, the earlier the signal crosses a threshold — the C value. To turn that into a quantity you need a standard curve of known standards (or a reference gene for relative fold-change), and pipetting, efficiency, and plateau effects all add noise to the read.
dPCR does the opposite: instead of watching amplification, it ends it and counts. The sample is split into thousands (chip) or millions (droplet) of wells or drops. After endpoint PCR, each partition is either positive (had a target molecule) or negative. The fraction of positive partitions, plus the known partition volume and Poisson statistics, gives an absolute copy number. No standard curve, no efficiency assumption, no threshold judgement.
That structural difference is the whole story. Because qPCR measures a continuous analog signal it is limited by amplification-to-amplification variance; because dPCR counts discrete digital events, a rare target’s positive droplets are detected directly rather than as a small bump on a noisy amplification curve.
Head-to-Head Comparison
| Feature | qPCR | dPCR |
|---|---|---|
| Quantification type | Relative (needs standard curve) | Absolute (copies/µL, no curve) |
| Limit of detection | ~10 copies / reaction | ~1–3 copies / reaction |
| Precision at low copies | CV >20% below ~10 copies | CV <10% down to ~3 copies |
| Dynamic range | 7–9 logs | 4–5 logs |
| Minimum allele frequency resolvable | ~1–5% (variation below is noise) | ~0.1% (and lower) |
| Detection chemistry | SYBR or probe; melt curve available | Probe only; no melt curve |
| Cost per reaction | ~$0.50–1 | ~$3–5 |
| Instrument cost | $20,000–50,000 | $50,000–100,000 |
| Throughput | 384-well, ~1–2 h | 96-well, ~2–3 h |
Two rows deserve emphasis. The precision row is why dPCR exists: below roughly ten copies, qPCR’s coefficient of variation climbs past 20%, while dPCR stays under 10% down to about three copies. And the resolvable-allele row is the “teeth”: qPCR cannot separate a 0.5% mutant signal from its background noise, whereas dPCR can count rare molecules directly.
When dPCR Genuinely Wins
These are the cases where dPCR’s cost is justified — and the ones worth crowdfunding a dedicated instrument for:
- Rare-allele detection in liquid biopsy. ctDNA at 0.5% variant allele frequency (VAF) is common in early-stage or post-treatment cancer. qPCR quantitation becomes unreliable in the 1–10% range (a QIAGEN technical note finds qPCR loses reliable quantification at ~10% mutant allele, where dPCR still works at 0.1%). PIK3CA or KRAS mutations at sub-1% abundance are dPCR territory.
- Copy-number variation with small fold-changes. Germline or somatic CNV of 1.2–1.5× is within qPCR’s noise if you only have a few copies; dPCR’s tight CV reads the small step reliably.
- Reference material qualification. When a NIST-standard or calibration material must carry an absolute value, no standard curve is acceptable. dPCR assigns traceable copy numbers without calibrators.
- Environmental monitoring with very low pathogen loads. Two or three intact genomes in a litre of water need the low detection limit dPCR was built for.
When qPCR Still Wins (Most of the Time)
Equally important, step back before you buy the dPCR machine:
- Large sample numbers. A 384-well qPCR plate screens hundreds of samples today. dPCR plate exhausts quickly and costs may stack.
- Gene expression with a big fold-change. Anything above ~2–3× is easy for qPCR; you only hit the precision wall if you lean on a 1.3× change.
- Budget-sensitive labs. At roughly $0.50–1 per qPCR reaction vs $3–5 for dPCR, across thousands of reactions the bill difference is real.
- Melt-curve specificity checking. With SYBR Green, a melt peak confirms you amplified one product. dPCR has no melt curve — if you value that check, stay with qPCR.
Worked Example: Detecting a 0.5% KRAS G12D Mutation in ctDNA
This is the scenario that makes the difference concrete. A patient’s circulating DNA contains wild-type KRAS at, say, 20,000 copies/mL, and we want to detect a mutant G12D allele present at 0.5% — about 100 mutant molecules.
Why qPCR fails here. qPCR sees the bulk. A 0.5% mutant allele shifts total amplification by less than one cycle (the mutant contributes a signal that is hundredths of a Ct), and that shift is inside qPCR’s run-to-run and replicate noise. Manufacturer guidance and real measurements put qPCR’s reliable allele-sensitivity in the ≥1–10% band — a 0.5% call reads as the wild-type curve with a barely visible shoulder, not a number you can trust or defend.
Why dPCR sees it. The same sample is partitioned and, by enhancing the mutant position, ~20,000 — or more — droplets endpoints. Roughly 0.5% of the droplets carry a mut-positive signal, i.e. around 100 positive drops in the mutant channel. Because each is counted on/off, not measured, those ~100 positives exceed the standard error almost automatically; the mutant allele frequency is read out as an absolute ratio. Published validations put dPCR’s reliable allele fraction around 0.1% — five times better than our 0.5% example, so this is a scenario you can actually reproduce.
The practical call. For a one-off 0.5% allele screen, buying dPCR capacity makes sense; for ongoing routine genotyping and expression across hundreds of samples, use qPCR and reserve dPCR (perhaps sent-out) for the rare-allele cases.
Cost Analysis for Indian Labs
In India the instrument gap is stark: a qPCR system (Bio-Rad CFX96 or equivalent) runs roughly ₹15–25 lakh; a dPCR system (QX200-class) lands at ₹40–70 lakh. Per-reaction, dPCR is typically ₹400–1,200 vs ₹150–400 for qPCR. For the liquid-biopsy and reference-material workloads above, the cost per actionable result can favour dPCR precisely because its higher sensitivity cuts the number of repeats.
How Rapidly dPCR Platforms Are Closing the Gap
The tradeoffs are not glacial. New platforms slim the old “dPCR is slow and expensive” excuse:
- Naica Crystal: a 2D-crystal monolayer of ~30,000 droplets per run, imaged directly — no droplet reader needed.
- QIAcuity: nanoplate with ~26,000 wells per, run time around 90 minutes — near-qPCR timelines.
- QX600 (Bio-Rad): six-colour multiplexing, matching qPCR’s channel count.
As these reach routine labs, the “cost per partition” falls and dPCR’s niche widens — but for now the decision rule still holds: only buy the precision when you will actually use it.
Primer and Probe Design for dPCR
dPCR changes primer expectations. Because the read is endpoint and quantized, designs should:
- Keep amplicons short (60–120 bp) so fragments stay intact and partition evenly in the sample
- Use probe chemistry (TaqMan-style); SYBR intercalators cannot distinguish positive/negative as cleanly in dPCR, and there is no melt curve to rescue you
- Optimise GC so both droplet populations cluster hard; a wide cloud eats the partition math
Primers validating well in qPCR transfer to dPCR, but dPCR adds the amplicon-length and clustering demands above — worth checking before switching a whole assay.
Frequently Asked Questions
What is the main advantage of digital PCR over qPCR?
Absolute quantification. dPCR counts discrete positive events and reports copies/µL directly, with no standard curve and no dependence on amplification efficiency. That gives it better precision at low copy numbers (CV under 10% down to ~3 copies) and it can resolve rare alleles to about 0.1%.
When should I choose qPCR over digital PCR?
For routine gene expression, high-throughput screens (384-well plates), large sample counts, and relative fold-change work where the change is big. qPCR also retains SYBR melt-curve specificity checking and costs much less per reaction. If you do not need sub-1% allele resolution or absolute copy numbers, qPCR is the right tool.
How sensitive is digital PCR compared to qPCR?
dPCR reliably detects around 1–3 copies per reaction where qPCR struggles below about 10 copies (its CV climbs past 20%). In allele-frequency terms, dPCR can resolve near 0.1% variant frequency, whereas qPCR becomes unreliable in the 1–10% band.
Why is digital PCR more expensive than qPCR?
The instrument costs roughly twice as much (more partitions, dedicated reader) and consumables are pricier per reaction. In India a dPCR system lands at ₹40–70 lakh vs ₹15–25 lakh for qPCR, and per-reaction cost is roughly ₹400–1,200 vs ₹150–400.
Can qPCR detect a 0.5% mutation?
Unreliably. A 0.5% mutant allele shifts a bulk qPCR signal by a fraction of a threshold cycle, which is inside normal replicate noise. dPCR, by counting rare positive partitions directly, resolves 0.1% and lower, so a 0.5% KRAS G12D call is well within dPCR’s range.
Can I use the same primers for qPCR and dPCR?
Usually yes — primers that validate in qPCR transfer to dPCR. But dPCR adds demands: keep amplicons short (60–120 bp) so templates partition evenly, and prefer probe chemistry since there is no melt curve to rescue an intercalator (SYBR)-based read.
Design Primers for qPCR and dPCR
Validate primer pairs for endpoint imaging and qPCR·dPCR workflows in one view.
Try VigyanLLM Primer Free →